We’re excited to announce that Berkeley Lights and IsoPlexis are moving forward together as PhenomeX, a premier functional cell biology company. Visit Site

Accelerating Clinical Biomarker Discovery for Curative Medicines

Learn how to accelerate timelines for finding cures with IsoPlexis’ Functional Proteomics.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Identifying the functional cellular adaptations leading to drug-resistant tumors
Detecting rare subsets of highly functional “Superhero” Cells that correlate to anti-tumor response
Identifying functional biomarker of severe inflammation proves critical to fighting COVID-19
Enabling biomarker discovery with unique functional proteomics
Accelerating clinical biomarker discovery for curative medicines
A Deeper Look

More about this

Predict and Personalize Medicine with Functional Proteomics

Clinical biomarkers are critical for the acceleration of curative medicines. Functional biomarkers can be used to predict response, identify potential effective treatments, and monitor a patient’s response to treatment.

Download this eBook to learn how IsoPlexis’ Functional Proteomics reveals unique insights over methods such as mass spectrometry, genomics, and epigenetics and provides high-throughput omics while simplifying complex workflows.

Get the